<PubmedArticle>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">26691210</PMID>
<DateCompleted>
<Year>2016</Year>
<Month>10</Month>
<Day>20</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1523-5866</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>18</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2016</Year>
<Month>Feb</Month>
</PubDate>
</JournalIssue>
<Title>Neuro-oncology</Title>
<ISOAbbreviation>Neuro-oncology</ISOAbbreviation>
</Journal>
<ArticleTitle>Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma.</ArticleTitle>
<Pagination>
<MedlinePgn>283-90</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1093/neuonc/nov307</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The majority of WHO grades II and III gliomas harbor a missense mutation in the metabolic gene isocitrate dehydrogenase (IDH) and accumulate the metabolite R-2-hydroxyglutarate (R-2HG). Prior studies showed that this metabolite can be detected in vivo using proton magnetic-resonance spectroscopy (MRS), but the sensitivity of this methodology and its clinical implications are unknown.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We developed an MR imaging protocol to integrate 2HG-MRS into routine clinical glioma imaging and examined its performance in 89 consecutive glioma patients.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Detection of 2-hydroxyglutarate (2HG) in IDH-mutant gliomas was closely linked to tumor volume, with sensitivity ranging from 8% for small tumors (&lt;3.4 mL) to 91% for larger tumors (&gt;8 mL). In patients undergoing 2HG-MRS prior to surgery, tumor levels of 2HG corresponded with tumor cellularity but not with tumor grade or mitotic index. Cytoreductive therapy resulted in a gradual decrease in 2HG levels with kinetics that closely mirrored changes in tumor volume.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our study demonstrates that 2HG-MRS can be linked with routine MR imaging to provide quantitative measurements of 2HG in glioma and may be useful as an imaging biomarker to monitor the abundance of IDH-mutant tumor cells noninvasively during glioma therapy and disease monitoring.</AbstractText>
<CopyrightInformation>Â© The Author(s) 2015. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>de la Fuente</LastName>
<ForeName>Macarena I</ForeName>
<Initials>MI</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Young</LastName>
<ForeName>Robert J</ForeName>
<Initials>RJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rubel</LastName>
<ForeName>Jennifer</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rosenblum</LastName>
<ForeName>Marc</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tisnado</LastName>
<ForeName>Jamie</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Briggs</LastName>
<ForeName>Samuel</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Arevalo-Perez</LastName>
<ForeName>Julio</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cross</LastName>
<ForeName>Justin R</ForeName>
<Initials>JR</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Campos</LastName>
<ForeName>Carl</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Straley</LastName>
<ForeName>Kimberly</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhu</LastName>
<ForeName>Dongwei</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dong</LastName>
<ForeName>Chuanhui</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Thomas</LastName>
<ForeName>Alissa</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Omuro</LastName>
<ForeName>Antonio A</ForeName>
<Initials>AA</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nolan</LastName>
<ForeName>Craig P</ForeName>
<Initials>CP</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pentsova</LastName>
<ForeName>Elena</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kaley</LastName>
<ForeName>Thomas J</ForeName>
<Initials>TJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Oh</LastName>
<ForeName>Jung H</ForeName>
<Initials>JH</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Noeske</LastName>
<ForeName>Ralph</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Maher</LastName>
<ForeName>Elizabeth</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Choi</LastName>
<ForeName>Changho</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gutin</LastName>
<ForeName>Philip H</ForeName>
<Initials>PH</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Holodny</LastName>
<ForeName>Andrei I</ForeName>
<Initials>AI</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yen</LastName>
<ForeName>Katharine</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>DeAngelis</LastName>
<ForeName>Lisa M</ForeName>
<Initials>LM</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mellinghoff</LastName>
<ForeName>Ingo K</ForeName>
<Initials>IK</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Thakur</LastName>
<ForeName>Sunitha B</ForeName>
<Initials>SB</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (M.I.d., S.B., A.T., A.A.O., C.P.N., E.P., T.J.K., L.M.D., I.K.M.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York (R.J.Y., J.R., J.T., J.A.-P., A.I.H., S.B.T.); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (M.R.); Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, New York (J.R.C.); Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York (C.C., I.K.M.); Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York (P.H.G.); Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York (J.H.O., S.B.T.); Agios Pharmaceuticals, Cambridge, Massachusetts (K.S., D.Z., K.Y.); Department of Neurology, Evelyn F. McKnight Brain Institute, University of Miami, Miami, Florida (C.D.); Advanced Imaging Research Center, University Of Texas Southwestern Medical Center, Dallas, Texas (E.M., C.C.); GE Healthcare, Berlin, Germany (R.N.); Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York (I.K.M.).</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P30 CA008748</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 NS080944</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>1R01NS080944-01</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30-CA008748</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>12</Month>
<Day>20</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Neuro Oncol</MedlineTA>
<NlmUniqueID>100887420</NlmUniqueID>
<ISSNLinking>1522-8517</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D005977">Glutarates</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>2889-31-8</RegistryNumber>
<NameOfSubstance UI="C019417">alpha-hydroxyglutarate</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.1.1.41</RegistryNumber>
<NameOfSubstance UI="D007521">Isocitrate Dehydrogenase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001932">Brain Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005910">Glioma</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005977">Glutarates</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007521">Isocitrate Dehydrogenase</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D060787">Neoplasm Grading</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D017410">Practice Guidelines as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011379">Prognosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D066244">Proton Magnetic Resonance Spectroscopy</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">IDH</Keyword>
<Keyword MajorTopicYN="N">R-2-hydroxyglutarate</Keyword>
<Keyword MajorTopicYN="N">cancer metabolism</Keyword>
<Keyword MajorTopicYN="N">glioma</Keyword>
<Keyword MajorTopicYN="N">imaging biomarker</Keyword>
<Keyword MajorTopicYN="N">magnetic resonance spectroscopy</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2015</Year>
<Month>11</Month>
<Day>14</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2015</Year>
<Month>11</Month>
<Day>14</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2015</Year>
<Month>12</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2015</Year>
<Month>12</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2016</Year>
<Month>10</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">26691210</ArticleId>
<ArticleId IdType="pii">nov307</ArticleId>
<ArticleId IdType="doi">10.1093/neuonc/nov307</ArticleId>
<ArticleId IdType="pmc">PMC4724186</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Science. 2013 May 3;340(6132):626-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23558169</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Magn Reson Imaging. 2008 Jul;26(6):847-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18486392</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Pathol. 2009 Apr;174(4):1149-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19246647</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Brain Tumor Res Treat. 2015 Apr;3(1):8-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25977902</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Radiographics. 2006 Oct;26 Suppl 1:S173-89</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17050514</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2013 Mar 29;339(6127):1621-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23393090</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Exp Med. 2010 Feb 15;207(2):339-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20142433</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2015 Jun 25;372(26):2481-98</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26061751</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2009 Dec 10;462(7274):739-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19935646</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Transl Med. 2012 Jan 11;4(116):116ra4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22238332</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Blood. 2013 Jun 13;121(24):4917-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23641016</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Cell. 2010 May 18;17(5):510-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20399149</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Magn Reson. 2005 Jul;175(1):79-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15949751</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2015 Jun 25;372(26):2499-508</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26061753</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Blood. 2012 Nov 29;120(23):4649-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23074281</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2009 Feb 19;360(8):765-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19228619</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2014 Jan 10;343(6167):189-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24336570</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann N Y Acad Sci. 1987;508:333-48</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3326459</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 2012 Apr;18(4):624-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22281806</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2012 Mar 22;483(7390):484-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22343896</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Magn Reson Med. 1999 Jun;41(6):1162-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10371448</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>NMR Biomed. 2000 May;13(3):129-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10861994</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>NMR Biomed. 1997 Dec;10(8):394-410</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9542737</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Cancer. 2012 Aug 1;131(3):766-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21913188</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Res. 2014 Sep 1;74(17):4622-37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25183787</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2012 Mar 22;483(7390):479-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22343889</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</PubmedArticle>